News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Degnan Chris
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.9593, valued at
$19.6k
|
|
| 02/28/2023 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 185,000 options to buy
@ $1.78, valued at
$329.3k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 74,435 options to buy
@ $14.84, valued at
$1.1M
|
|
| 11/08/2019 |
4
| Degnan Chris (CFO) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 229,513 options
@ $12, valued at
$2.8M
|
|
| 11/06/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/04/2019 |
4
| Degnan Chris (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Granted 44,000 options to buy
@ $11.32, valued at
$498.1k
|
|
| 08/15/2018 |
4
| Degnan Chris (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.|
Txns:
| Bought 3,000 shares
@ $15, valued at
$45k
|
|
| 06/14/2018 |
3
| Degnan Chris (CFO) has filed a Form 3 on Verrica Pharmaceuticals Inc. |
|
|